Related Experiment Video
Updated: Jun 1, 2026

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
Cardiovascular complications in children with HIV infection
1Pediatric Cardiology, Children's National Medical Center, Washington, DC 20010, USA. asims@cnmc.org
Insights
Cardiovascular complications in children with HIV have shifted from acute to chronic issues due to effective treatment. Research now focuses on understanding and mitigating long-term cardiac risks in these children.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Public Health
Background:
- Cardiovascular complications were a primary cause of death in children with human immunodeficiency virus (HIV) before effective antiretroviral treatment (ART).
- With ART as standard care, the focus has shifted from acute cardiac events to understanding cardiovascular issues as a chronic manifestation of HIV and its management.
- This highlights the evolving landscape of pediatric HIV care and its long-term health implications.
Purpose of the Study:
- To review recent advancements in understanding the impact of HIV and its treatment on cardiovascular health in children.
- To explore the roles of atherosclerosis, inflammation, biomarkers, and metabolic abnormalities in cardiac function and disease risk.
- To identify emerging cardiovascular health challenges and strategies for risk reduction in HIV-infected children.
Main Methods:
- Literature review of recent research on cardiovascular complications in pediatric HIV.
- Analysis of studies investigating the mechanisms linking HIV, ART, and cardiovascular disease.
- Synthesis of current knowledge on risk factors and emerging health challenges.
Main Results:
- HIV and its treatment are associated with chronic cardiovascular changes, including atherosclerosis and inflammation.
- Biomarkers and metabolic abnormalities play significant roles in cardiac function and cardiovascular disease risk.
- The full extent of cardiovascular outcomes in HIV-infected children remains under investigation.
Conclusions:
- Children with HIV face evolving cardiovascular health challenges beyond acute complications.
- Further research is needed to fully characterize cardiovascular disease risk and implement effective prevention strategies.
- Proactive cardiovascular risk management is crucial for improving long-term health outcomes in pediatric HIV populations.
Abstract:
Before effective antiretroviral treatment was introduced in children with HIV, cardiovascular complications were a major cause of morbidity and mortality. Now that antiretroviral treatment is the standard of care in this population, there has been a shift from fulminant cardiovascular complications to recognition of cardiovascular issues related to HIV as a chronic disease state and its treatment. This review explores the recent advances in understanding the roles of atherosclerosis, inflammation, biomarkers, and metabolic abnormalities in cardiac function and cardiovascular disease risk in children with HIV. The true risk and prevalence of cardiovascular outcomes in HIV-infected children and adolescents has yet to be realized. Recently, however, investigators are exploring new cardiovascular health challenges that face children living with HIV, and developing strategies to lower the cardiovascular disease risk for these children.
More Related Videos
Related Concept Videos
Complications of Diabetes Mellitus
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Hemodialysis II: Procedure and Complications
Pharmacokinetics in Pediatric Patients: Drug Excretion
Cryptococcal Meningitis
Chronic Kidney Disease II: Clinical Manifestations

